<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-130276</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">New antiplatelet drugs in coronary artery disease</dc:title>
<dc:description xml:lang="en">The dual antiplatelet therapy with acetylsalicylic acid and clopidogrel has been the mainstay of both acute and chronic phase coronary artery disease, reducing importantly the risk of adverse events. Despite a correct compliance, a non-negligible rate of adverse events still happens. New compounds, with improved properties, are now clinically available (such as prasugrel or ticagrelor) or under advanced development. The aim of the present review is the description of these new compounds, particularly prasugrel and ticagrelor (AU)</dc:description>
<dc:creator>Valdés, Mariano</dc:creator>
<dc:creator>Jover, Eva</dc:creator>
<dc:creator>Tello-Montoliu, Antonio</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El doble tratamiento antiagregante con ácido acetilsalicílico y clopidogrel reduce considerablemente las complicaciones trombóticas de las fases aguda y crónica en la cardiopatía isquémica. Pese al buen cumplimiento terapéutico, un porcentaje no despreciable de pacientes continúa presentando episodios adversos. Por ello, nuevos compuestos farmacológicamente más favorables están ya disponibles clínicamente (como es el caso de prasugrel y ticagrelor) o en fases avanzadas de su desarrollo. La presente revisión tiene como objetivo principal la descripción de los nuevos fármacos antiagregantes, en especial prasugrel y ticagrelor (AU)</dc:description>
<dc:source>Med. clín (Ed. impr.);143(11): 508-514, dic. 2014. tab</dc:source>
<dc:identifier>ibc-130276</dc:identifier>
<dc:title xml:lang="es">Nuevos antiagregantes plaquetarios en cardiopatía isquémica</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d252</dc:subject>
<dc:subject>^d54169^s22079</dc:subject>
<dc:subject>^d22965^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30650^s22057</dc:subject>
<dc:subject>^d55037^s22061</dc:subject>
<dc:subject>^d54033^s22079</dc:subject>
<dc:type>article</dc:type>
<dc:date>201412</dc:date>
</metadata>
</record>
</ibecs-document>
